The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

ServiceNow is buying AI startup Moveworks for $2.85 billion, the enterprise software firm announced first thing this morning, ...

Today, we’re diving into a major policy paper co-authored by former Google CEO Eric Schmidt, Scale AI CEO Alexandr Wang, and ...

NEW YORK – Contract research organization Anova Enterprises on Wednesday said that patients with newly diagnosed high-grade glioma are starting to receive Denovo Biopharma's gene therapy DB107 in a ...

NEW YORK – Hutchmed on Thursday said it has completed enrollment of a Phase II trial in China testing the FGFR1/2/3 inhibitor fanregratinib in patients with advanced intrahepatic cholangiocarcinoma ...

NEW YORK – Agilent Technologies said on Monday that it has received certification under the EU's In Vitro Diagnostic Regulation for the expanded use of a PD-L1 assay as a companion diagnostic test to ...

NEW YORK – Blood-based testing continues to expand within neurology as researchers and clinicians pursue less expensive and less invasive tools for diagnosing and managing neurodegenerative disease.